OpenLB
Open Library of Bioscience
Advanced Search
Actas espanolas de psiquiatria
Jun, 2022;50 (Supplement): 77-138.

TOBACCO USE DISORDER AND DUAL DISORDERS Joint statement by the Spanish Psychiatry Society and the Spanish Dual Disorders Society.

Szerman N��stor, Parro Carlos, Pinet Cristina, Mart��nez-Raga Jos��, Basurte Ignacio, Saiz Pilar
Author Information
  1. Szerman N��stor: Instituto de Psiquiatr��a y Salud Mental, Hospital General Universitario Gregorio Mara����n, Madrid, Espa��a. Miembro de la Sociedad Espa��ola de Patolog��a Dual (SEPD).
  2. Parro Carlos: Instituto de Psiquiatr��a y Salud Mental, Hospital General Universitario Gregorio Mara����n, Madrid, Espa��a. Miembro de la Sociedad Espa��ola de Patolog��a Dual (SEPD).
  3. Pinet Cristina: Unidad Toxicoman��as, Servicio de Psiquiatr��a, Hospital Sant Pau, Barcelona, Espa��a. Miembro de la Sociedad Espa��ola de Psiquiatr��a (SEP).
  4. Mart��nez-Raga Jos��: Departamento de Psiquiatr��a y Psicolog��a M��dica. Hospital Universitario Doctor Peset y Universitat de Valencia. Valencia, Espa��a. Miembro de la Sociedad Espa��ola de Patolog��a Dual (SEPD).
  5. Basurte Ignacio: Direcci��n m��dica de Psiquiatr��a y Salud Mental de la Cl��nica L��pez Ibor. Madrid, Espa��a. Profesor vinculado de la Universidad Europea de Madrid. Madrid, Espa��a. Miembro de la Sociedad Espa��ola de Patolog��a Dual (SEPD).
  6. Saiz Pilar: Catedr��tica de Psiquiatr��a. Universidad de Oviedo, Centro de Investigaci��n Biom��dica en Red de Salud Mental (CIBERSAM), Instituto Universitario de Neurociencias del Principado de Asturias (INEUROPA), Instituto de Investigaci��n sanitaria del Principado de Asturias (ISPA), Servicio de Salud del Principado de Asturias (SESPA). Asturias, Espa��a. Miembro de la Sociedad Espa��ola de Psiquiatr��a (SEP).
PMID: 35731182

Abstract

TOBACCO USE DISORDER (TUD) is a health problem of the first order in the world population, affecting a vulnerable population, such as people with other mental disorders, whose morbidity and mortality are increased as a result.

References

  1. Schizophr Bull. 2019 Oct 24;45(6):1300-1308 [PMID: 30690638]
  2. Nicotine Tob Res. 2012 Feb;14(2):234-9 [PMID: 21778151]
  3. J Clin Psychiatry. 2014 Jul;75(7):765-72 [PMID: 25006684]
  4. Eur Neuropsychopharmacol. 2015 Dec;25(12):2318-25 [PMID: 26527055]
  5. Br J Psychiatry. 2012 Sep;201(3):207-14 [PMID: 22844023]
  6. Addiction. 2014 Jan;109(1):128-137 [PMID: 24033696]
  7. JAMA. 2010 Dec 8;304(22):2485-93 [PMID: 21139110]
  8. Harv Rev Psychiatry. 2015 Mar-Apr;23(2):90-8 [PMID: 25747922]
  9. Curr Neuropharmacol. 2018;16(4):338-349 [PMID: 28901280]
  10. Trends Pharmacol Sci. 2004 Jun;25(6):317-24 [PMID: 15165747]
  11. Med Clin (Barc). 1988 Mar 12;90(10):404-7 [PMID: 3398611]
  12. Nicotine Tob Res. 2001 Aug;3(3):225-34 [PMID: 11506766]
  13. BMC Psychiatry. 2017 Jul 14;17(1):252 [PMID: 28705244]
  14. J Nucl Med. 2015 Nov;56(11):1724-9 [PMID: 26272810]
  15. MMWR Morb Mortal Wkly Rep. 2013 Feb 8;62(5):81-7 [PMID: 23388551]
  16. Nicotine Tob Res. 2019 Aug 19;21(9):1220-1227 [PMID: 29912406]
  17. Annu Rev Public Health. 2010;31:297-314 1p following 314 [PMID: 20001818]
  18. Ann Intern Med. 2015 Oct 20;163(8):622-34 [PMID: 26389730]
  19. BMJ. 2008 May 31;336(7655):1223-7 [PMID: 18441375]
  20. Regul Toxicol Pharmacol. 2011 Mar;59(2):197-214 [PMID: 21163315]
  21. Drug Alcohol Depend. 2013 Jan 1;127(1-3):170-6 [PMID: 22809897]
  22. Int Rev Neurobiol. 2015;124:3-19 [PMID: 26472524]
  23. J Clin Psychiatry. 2018 Aug 28;79(5): [PMID: 30192444]
  24. Clin Psychopharmacol Neurosci. 2015 Apr 30;13(1):1-11 [PMID: 25912533]
  25. Nicotine Tob Res. 2018 Jan 5;20(2):173-182 [PMID: 28177498]
  26. JAMA Pediatr. 2017 Aug 1;171(8):788-797 [PMID: 28654986]
  27. Psychol Addict Behav. 2019 May;33(3):197-207 [PMID: 30829517]
  28. Front Psychiatry. 2020 Nov 24;11:589155 [PMID: 33329137]
  29. J Psychiatr Res. 2014 Jan;48(1):102-10 [PMID: 24139811]
  30. J Intellect Disabil Res. 2013 May;57(5):393-408 [PMID: 22458301]
  31. Addict Behav. 2019 Feb;89:98-103 [PMID: 30286397]
  32. J Consult Clin Psychol. 2004 Aug;72(4):723-8 [PMID: 15301657]
  33. J Clin Psychol. 2016 Mar;72(3):194-206 [PMID: 26783736]
  34. Anticancer Res. 2011 May;31(5):1527-34 [PMID: 21617206]
  35. Genes Brain Behav. 2016 Jan;15(1):74-88 [PMID: 26482647]
  36. J Affect Disord. 2019 Sep 1;256:267-277 [PMID: 31195244]
  37. Tob Control. 2014 Nov;23(e2):e147-53 [PMID: 24727731]
  38. Soc Sci Med. 2008 Aug;67(3):420-30 [PMID: 18486291]
  39. J Clin Psychiatry. 2008 Nov;69(11):1743-50 [PMID: 19026259]
  40. Subst Abus. 2009 Oct-Dec;30(4):295-305 [PMID: 19904665]
  41. Nicotine Tob Res. 2003 Aug;5(4):515-26 [PMID: 12959789]
  42. Intellect Dev Disabil. 2009 Jun;47(3):197-207 [PMID: 19489665]
  43. Nicotine Tob Res. 2020 Oct 8;22(10):1875-1882 [PMID: 32285121]
  44. J Dual Diagn. 2018 Jul-Sep;14(3):148-157 [PMID: 29693495]
  45. Cochrane Database Syst Rev. 2013 Aug 21;(8):CD006102 [PMID: 23963776]
  46. Rev Neurol. 2011 Oct 1;53(7):406-14 [PMID: 21948011]
  47. Adicciones. 2016 Jun 14;29(1):6-12 [PMID: 27391843]
  48. Am J Psychiatry. 2011 Apr;168(4):395-9 [PMID: 21245085]
  49. Front Psychiatry. 2015 Sep 08;6:125 [PMID: 26441686]
  50. Arch Intern Med. 1998 Oct 12;158(18):2035-9 [PMID: 9778204]
  51. Int J Environ Res Public Health. 2013 Dec 24;11(1):373-89 [PMID: 24368428]
  52. Psychol Med. 2017 Jan;47(2):193-197 [PMID: 27334937]
  53. J Atten Disord. 2014 Feb;18(2):158-68 [PMID: 22508760]
  54. Br J Addict. 1992 Jun;87(6):825-8; discussion 833-5 [PMID: 1525523]
  55. Am J Psychiatry. 2018 Jan 1;175(1):63-70 [PMID: 28838251]
  56. Cochrane Database Syst Rev. 2013 May 31;(5):CD009329 [PMID: 23728690]
  57. Addict Behav. 2019 Mar;90:136-142 [PMID: 30391774]
  58. Nicotine Tob Res. 2018 Jan 5;20(2):161-172 [PMID: 28177489]
  59. Addiction. 2018 Dec;113(12):2280-2289 [PMID: 30066385]
  60. BMJ. 2004 Jun 26;328(7455):1519 [PMID: 15213107]
  61. J Abnorm Psychol. 2014 May;123(2):362-374 [PMID: 24886010]
  62. BMC Public Health. 2011 Apr 22;11:256 [PMID: 21513510]
  63. Nicotine Tob Res. 2016 May;18(5):509-23 [PMID: 26508396]
  64. J Clin Psychiatry. 2018 Aug 14;79(5): [PMID: 30153404]
  65. World Psychiatry. 2007 Oct;6(3):177-85 [PMID: 18188443]
  66. Addict Behav. 2016 Aug;59:30-4 [PMID: 27043170]
  67. BMJ. 2014 Feb 13;348:g1151 [PMID: 24524926]
  68. Biol Psychiatry. 2004 Jan 1;55(1):69-76 [PMID: 14706427]
  69. J Dual Diagn. 2017 Jan-Mar;13(1):15-20 [PMID: 27918881]
  70. Depress Anxiety. 2020 Mar;37(3):247-260 [PMID: 31850603]
  71. J Consult Clin Psychol. 2020 Oct;88(10):951-964 [PMID: 33048571]
  72. Prev Med. 2000 Feb;30(2):115-25 [PMID: 10656839]
  73. Tob Induc Dis. 2009 Jan 30;5:3 [PMID: 19183452]
  74. Addiction. 2019 Mar;114(3):515-522 [PMID: 30370685]
  75. Sci Adv. 2019 Oct 16;5(10):eaay9763 [PMID: 31663029]
  76. Eur J Neurosci. 2019 Sep;50(6):3014-3027 [PMID: 30968489]
  77. Nicotine Tob Res. 2020 Mar 16;22(3):354-362 [PMID: 30590810]
  78. Aust N Z J Psychiatry. 2022 Feb;56(2):164-177 [PMID: 33908298]
  79. Annu Rev Public Health. 2017 Mar 20;38:165-185 [PMID: 27992725]
  80. Addict Biol. 2010 Jul;15(3):250-65 [PMID: 20456288]
  81. J Consult Clin Psychol. 2004 Dec;72(6):1144-56 [PMID: 15612860]
  82. J Psychopharmacol. 2012 Jul;26(7):899-952 [PMID: 22628390]
  83. J Clin Psychiatry. 2016 Oct;77(10):1404-1412 [PMID: 27135834]
  84. Eur Psychiatry. 2014 Feb;29(2):65-82 [PMID: 24485753]
  85. J Clin Med. 2020 Jul 28;9(8): [PMID: 32731398]
  86. Cochrane Database Syst Rev. 2016 Nov 23;11:CD010274 [PMID: 27878808]
  87. Clin Interv Aging. 2015 Apr 10;10:687-93 [PMID: 25914527]
  88. Curr Psychiatry Rep. 2002 Oct;4(5):388-96 [PMID: 12230968]
  89. J Dual Diagn. 2015;11(1):50-5 [PMID: 25491589]
  90. Nicotine Tob Res. 2011 Oct;13(10):1003-8 [PMID: 21652734]
  91. BMC Psychiatry. 2020 Jun 23;20(1):326 [PMID: 32576169]
  92. Ann Epidemiol. 2014 Aug;24(8):620-4 [PMID: 25084705]
  93. J Clin Psychopharmacol. 2001 Feb;21(1):94-8 [PMID: 11199956]
  94. Addict Biol. 2003 Mar;8(1):13-21 [PMID: 12745411]
  95. Clin Exp Hypertens. 2017;39(5):441-447 [PMID: 28590147]
  96. Therapie. 2021 Mar-Apr;76(2):127-136 [PMID: 33371988]
  97. Am J Psychiatry. 2021 Sep 1;178(9):783-785 [PMID: 34516230]
  98. Am J Addict. 2012 Sep-Oct;21(5):416-23 [PMID: 22882392]
  99. Tob Control. 2012 Nov;21(6):549-54 [PMID: 21933940]
  100. Lancet Psychiatry. 2020 Sep;7(9):762-774 [PMID: 32828166]
  101. BMC Pharmacol Toxicol. 2019 Nov 21;20(1):69 [PMID: 31753009]
  102. Am J Drug Alcohol Abuse. 1998 Nov;24(4):617-25 [PMID: 9849772]
  103. Am J Public Health. 2016 Aug;106(8):1483-90 [PMID: 27310347]
  104. Int J Ment Health Syst. 2021 Mar 3;15(1):22 [PMID: 33658061]
  105. J Psychiatr Res. 2020 Jun;125:121-128 [PMID: 32272242]
  106. Drug Alcohol Depend. 2020 Jan 1;206:107756 [PMID: 31786396]
  107. JAMA. 2014 Jan 8;311(2):145-54 [PMID: 24399553]
  108. Neurosci Lett. 2018 Mar 6;668:98-102 [PMID: 29339170]
  109. Psychiatr Serv. 1995 May;46(5):435-6 [PMID: 7627666]
  110. Eur Addict Res. 2019;25(5):256-262 [PMID: 31163435]
  111. Psychiatr Serv. 2013 Jan;64(1):44-50 [PMID: 23280457]
  112. Drug Alcohol Depend. 2010 Apr 1;108(1-2):141-5 [PMID: 20079976]
  113. Chest. 2002 Aug;122(2):403-8 [PMID: 12171809]
  114. Drug Alcohol Depend. 2017 Oct 1;179:18-24 [PMID: 28738266]
  115. Health Technol Assess. 2018 Aug;22(41):1-84 [PMID: 30079863]
  116. J Consult Clin Psychol. 2001 Apr;69(2):215-26 [PMID: 11393599]
  117. Addict Behav. 2017 Aug;71:89-95 [PMID: 28285208]
  118. Curr Drug Abuse Rev. 2017;9(2):76-79 [PMID: 27492358]
  119. Psychopharmacology (Berl). 2020 Jan;237(1):11-19 [PMID: 31792645]
  120. N Engl J Med. 2010 Jun 17;362(24):2295-303 [PMID: 20554984]
  121. Rev Mal Respir. 2016 Mar;33(3):241-7 [PMID: 26363671]
  122. Neuropharmacology. 2015 Sep;96(Pt B):178-93 [PMID: 25660637]
  123. Nicotine Tob Res. 2014 Nov;16(11):1417-28 [PMID: 24939916]
  124. JAMA Pediatr. 2019 Dec 1;173(12):1146-1153 [PMID: 31609433]
  125. JAMA. 2000 Nov 22-29;284(20):2606-10 [PMID: 11086367]
  126. JAMA. 2014 Jan 8;311(2):197-9 [PMID: 24399560]
  127. Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15037-42 [PMID: 21402948]
  128. Hum Exp Toxicol. 2017 Nov;36(11):1115-1120 [PMID: 27932538]
  129. Addict Behav. 2014 Dec;39(12):1755-8 [PMID: 25123341]
  130. J Am Acad Child Adolesc Psychiatry. 2004 Feb;43(2):199-205 [PMID: 14726727]
  131. Nicotine Tob Res. 2008 Dec;10(12):1793-809 [PMID: 19023831]
  132. Addiction. 2011 Feb;106(2):418-27 [PMID: 20973856]
  133. Acta Neuropathol. 2014 Jan;127(1):53-69 [PMID: 24240736]
  134. JAMA. 2014 Jan 8;311(2):172-82 [PMID: 24399556]
  135. Nicotine Tob Res. 2008 May;10(5):875-81 [PMID: 18569762]
  136. J Consult Clin Psychol. 2004 Aug;72(4):729-35 [PMID: 15301658]
  137. Lancet Psychiatry. 2019 May;6(5):379-390 [PMID: 30975539]
  138. Neurotoxicology. 2017 Mar;59:22-26 [PMID: 28057462]
  139. Am J Prev Med. 2019 Oct;57(4):429-437 [PMID: 31443956]
  140. Eur Neuropsychopharmacol. 2015 Feb;25(2):176-84 [PMID: 25028065]
  141. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006103 [PMID: 17253581]
  142. J Gambl Stud. 2015 Sep;31(3):1107-17 [PMID: 25753359]
  143. Arch Pediatr Adolesc Med. 2000 Jan;154(1):31-7 [PMID: 10632247]
  144. BMJ Open. 2018 Jun 11;8(6):e021114 [PMID: 29895653]
  145. Psychol Rev. 2004 Jan;111(1):33-51 [PMID: 14756584]
  146. Nicotine Tob Res. 2021 May 24;23(6):1010-1018 [PMID: 33277655]
  147. Drug Alcohol Rev. 2006 Jan;25(1):73-8 [PMID: 16492579]
  148. Addict Health. 2017 Jul;9(3):129-138 [PMID: 29657693]
  149. Health Psychol Res. 2020 Oct 13;8(2):9237 [PMID: 33123649]
  150. Arch Gen Psychiatry. 2004 Nov;61(11):1107-15 [PMID: 15520358]
  151. Arch Gen Psychiatry. 1998 Aug;55(8):683-90 [PMID: 9707377]
  152. Chem Biol Drug Des. 2016 May;87(5):737-46 [PMID: 26684482]
  153. Drug Alcohol Depend. 2000 May 1;59 Suppl 1:S41-60 [PMID: 10773437]
  154. Behav Med. 2020 Apr-Jun;46(2):161-169 [PMID: 31039083]
  155. Neuropsychopharmacology. 2018 Jul;43(8):1712-1720 [PMID: 29695783]
  156. Alzheimers Dement. 2014 Jun;10(3 Suppl):S122-45 [PMID: 24924665]
  157. Cochrane Database Syst Rev. 2013 Aug 12;(8):CD002850 [PMID: 23934971]
  158. Borderline Personal Disord Emot Dysregul. 2018 Sep 19;5:15 [PMID: 30250740]
  159. J Nucl Med. 2007 Nov;48(11):1829-35 [PMID: 17942810]
  160. Transl Psychiatry. 2013 Oct 01;3:e308 [PMID: 24084939]
  161. Am J Prev Med. 2015 Sep;49(3):362-9 [PMID: 26071864]
  162. Am J Addict. 2018 Jan;27(1):35-36 [PMID: 29283486]
  163. Subst Use Misuse. 2018 Feb 23;53(3):432-445 [PMID: 29039714]
  164. CNS Drugs. 2009 Aug;23(8):661-8 [PMID: 19594195]
  165. Lancet. 2016 Jun 18;387(10037):2507-20 [PMID: 27116918]
  166. Adicciones. 2019 Sep 01;31(4):298-308 [PMID: 31018000]
  167. Gac Sanit. 2016 Jan-Feb;30(1):55-8 [PMID: 26422688]
  168. Depress Anxiety. 2012 Apr;29(4):295-306 [PMID: 22147558]
  169. Int J Environ Res Public Health. 2017 Aug 29;14(9): [PMID: 28850065]
  170. J Clin Psychiatry. 2010 Dec;71(12):1680-8 [PMID: 20492837]
  171. Alzheimers Dement. 2015 Jun;11(6):718-26 [PMID: 26045020]
  172. Tob Control. 2004 Jun;13(2):206 [PMID: 15175544]
  173. J Pediatr Pharmacol Ther. 2010 Oct;15(4):249-63 [PMID: 22477813]
  174. BMC Public Health. 2021 Jun 3;21(1):954 [PMID: 34078351]
  175. Expert Rev Respir Med. 2017 Oct;11(10):841-850 [PMID: 28756728]
  176. Addiction. 2021 Oct;116(10):2847-2858 [PMID: 33761149]
  177. J Clin Psychopharmacol. 2019 Jul/Aug;39(4):398-402 [PMID: 31188242]
  178. J Subst Abuse Treat. 2017 Apr;75:62-96 [PMID: 28153483]
  179. Am J Drug Alcohol Abuse. 2018;44(6):653-659 [PMID: 29370538]
  180. J Psychoactive Drugs. 2007 Dec;39(4):423-33 [PMID: 18303699]
  181. N Engl J Med. 2002 Oct 3;347(14):1087-93 [PMID: 12362011]
  182. Addiction. 2016 Apr;111(4):599-612 [PMID: 26594837]
  183. Methodist Debakey Cardiovasc J. 2015 Jul-Sep;11(3):156-9 [PMID: 26634022]
  184. Lancet Public Health. 2020 Nov;5(11):e577 [PMID: 33120038]
  185. Behav Neurosci. 2014 Dec;128(6):713-21 [PMID: 25314662]
  186. Pharmacol Rep. 2006 Nov-Dec;58(6):777-98 [PMID: 17220536]
  187. PLoS One. 2017 Dec 5;12(12):e0188849 [PMID: 29206852]
  188. Prev Chronic Dis. 2006 Apr;3(2):A42 [PMID: 16539783]
  189. J Behav Addict. 2012 Dec;1(4):180-5 [PMID: 26165605]
  190. Int J Soc Psychiatry. 2004 Sep;50(3):204-15 [PMID: 15511114]
  191. Psychopharmacology (Berl). 2020 Apr;237(4):1223-1231 [PMID: 31938877]
  192. Am J Addict. 2013 Mar-Apr;22(2):93-8 [PMID: 23414492]
  193. Addiction. 2002 Dec;97(12):1493-504 [PMID: 12472629]
  194. Multivariate Behav Res. 1991 Jan 1;26(1):83-107 [PMID: 26782613]
  195. Trials. 2019 Jan 11;20(1):38 [PMID: 30635072]
  196. Psychiatr Serv. 2004 Nov;55(11):1258-64 [PMID: 15534014]
  197. Curr Addict Rep. 2019 Jun;6(2):86-97 [PMID: 32010548]
  198. J Dual Diagn. 2017 Oct-Dec;13(4):238-246 [PMID: 28489501]
  199. Addiction. 2019 May;114(5):923-933 [PMID: 30589984]
  200. NIDA Res Monogr. 1979 Jun;(25):191-200 [PMID: 117369]
  201. Sci Rep. 2017 Nov 17;7(1):13825 [PMID: 29150612]
  202. Addiction. 2021 Nov;116(11):2978-2994 [PMID: 33620737]
  203. J Neuroimmune Pharmacol. 2016 Sep;11(3):471-83 [PMID: 26872457]
  204. Drug Alcohol Depend. 2017 Apr 01;173:191-199 [PMID: 28209289]
  205. J Subst Abuse. 1995;7(3):373-8 [PMID: 8749796]
  206. Rev Psiquiatr Salud Ment. 2016 Oct - Dec;9(4):181-184 [PMID: 27969002]
  207. Sci Rep. 2020 Aug 14;10(1):13807 [PMID: 32796876]
  208. Am J Drug Alcohol Abuse. 2017 Jan;43(1):55-60 [PMID: 27441452]
  209. BMC Psychiatry. 2021 Apr 23;21(1):209 [PMID: 33892659]
  210. N Engl J Med. 2019 Feb 14;380(7):629-637 [PMID: 30699054]
  211. J Dual Diagn. 2020 Oct;16(4):420-428 [PMID: 32735514]
  212. Nicotine Tob Res. 2020 Jan 27;22(1):58-65 [PMID: 31056710]
  213. Nicotine Tob Res. 2019 Jan 4;21(2):156-162 [PMID: 29471329]
  214. Am J Physiol Lung Cell Mol Physiol. 2015 Jul 15;309(2):L175-87 [PMID: 25979079]
  215. Behav Pharmacol. 2008 Sep;19(5-6):461-84 [PMID: 18690103]
  216. Front Public Health. 2021 Jul 05;9:664748 [PMID: 34291026]
  217. Am J Psychiatry. 2012 Aug;169(8):851-9 [PMID: 22772158]
  218. Drug Alcohol Depend. 2015 Sep 1;154:14-24 [PMID: 26094185]
  219. Br J Health Psychol. 2020 Sep;25(3):615-638 [PMID: 32678937]
  220. Am J Addict. 2016 Oct;25(7):533-41 [PMID: 27589072]
  221. Arch Gerontol Geriatr. 2013 Jan-Feb;56(1):214-9 [PMID: 22995342]
  222. Int J Environ Res Public Health. 2016 Feb 25;13(3): [PMID: 26927143]
  223. J Geriatr Psychiatry Neurol. 2013 Dec;26(4):199-208 [PMID: 23877565]
  224. Am J Public Health. 2001 Feb;91(2):296-9 [PMID: 11211643]
  225. JAMA. 2021 Jul 6;326(1):56-64 [PMID: 34228066]
  226. Pediatrics. 2008 Sep;122(3):e595-600 [PMID: 18762494]
  227. Psychiatr Serv. 2018 Mar 1;69(3):274-280 [PMID: 29137560]
  228. Eur Psychiatry. 2004 Apr;19(2):102-12 [PMID: 15132126]
  229. Am J Public Health. 2007 Aug;97(8):1503-9 [PMID: 17600268]
  230. Subst Abuse Treat Prev Policy. 2011 Jul 19;6:17 [PMID: 21771314]
  231. J Intellect Disabil Res. 2018 Aug;62(8):709-718 [PMID: 29920831]
  232. J Subst Abuse Treat. 2010 Mar;38(2):191-9 [PMID: 20015608]
  233. Lancet Child Adolesc Health. 2020 Nov;4(11):837-845 [PMID: 32979939]
  234. J Clin Psychopharmacol. 2019 Mar/Apr;39(2):108-116 [PMID: 30811371]
  235. Am J Psychiatry. 2021 Sep 1;178(9):818-828 [PMID: 34080890]
  236. Clin Psychol Rev. 2011 Apr;31(3):328-41 [PMID: 21382538]
  237. Trends Cogn Sci. 2014 Apr;18(4):211-7 [PMID: 24612993]
  238. Am J Public Health. 2010 Dec;100(12):2464-72 [PMID: 20966369]
  239. PLoS One. 2016 Jan 05;11(1):e0143490 [PMID: 26730716]
  240. Nicotine Tob Res. 2005 Aug;7(4):491-9 [PMID: 16085520]
  241. Schizophr Res. 2017 May;183:124-129 [PMID: 27956009]
  242. JMIR Serious Games. 2016 Oct 24;4(2):e18 [PMID: 27777216]
  243. N Engl J Med. 2014 Dec 18;371(25):2353-62 [PMID: 25517706]
  244. Am J Psychiatry. 2020 Feb 1;177(2):113-116 [PMID: 32008390]
  245. Psychol Med. 2004 Feb;34(2):323-33 [PMID: 14982138]
  246. Biol Psychiatry. 2013 Sep 15;74(6):436-43 [PMID: 23660272]
  247. Tob Control. 2018 Jan;27(1):18-25 [PMID: 28970328]
  248. J Subst Abuse Treat. 2011 Jan;40(1):77-86 [PMID: 20934835]
  249. Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14065-9 [PMID: 8943061]
  250. CNS Drugs. 2017 Jun;31(6):471-481 [PMID: 28550660]
  251. J Child Psychol Psychiatry. 2018 Jun;59(6):692-702 [PMID: 29315559]
  252. Tob Control. 2020 Jul;29(4):381-387 [PMID: 31209129]
  253. JAMA Psychiatry. 2013 Jul;70(7):740-9 [PMID: 23754458]
  254. J Dual Diagn. 2018 Oct-Dec;14(4):237-246 [PMID: 30638153]
  255. BMC Cancer. 2015 Mar 19;15:152 [PMID: 25885699]
  256. Aust N Z J Psychiatry. 2017 Apr;51(4):366-381 [PMID: 28195010]
  257. Addiction. 2009 May;104(5):719-33 [PMID: 19413788]
  258. Adicciones. 2022 Jul 01;34(3):218-226 [PMID: 33338247]
  259. Am J Prev Med. 2018 Jun;54(6):736-745 [PMID: 29656916]
  260. J Pediatr Psychol. 2018 Mar 1;43(2):162-171 [PMID: 29049706]
  261. Clin Pharmacol Ther. 2013 Dec;94(6):687-94 [PMID: 23933970]
  262. Am J Psychiatry. 1986 Aug;143(8):993-7 [PMID: 3487983]
  263. Arch Bronconeumol. 2016 Dec;52(12):605-610 [PMID: 26905777]
  264. Cochrane Database Syst Rev. 2016 Mar 24;3:CD008286 [PMID: 27009521]
  265. Addict Behav. 2015 Jan;40:16-20 [PMID: 25218066]
  266. Neuron. 2012 Oct 4;76(1):116-29 [PMID: 23040810]
  267. Annu Rev Psychol. 2001;52:685-716 [PMID: 11148322]
  268. Neuropsychopharmacology. 2015 Dec;40(13):3053-60 [PMID: 26089183]
  269. JMIR Serious Games. 2018 Jan 16;6(1):e2 [PMID: 29339346]
  270. Nutrients. 2020 Dec 15;12(12): [PMID: 33334010]
  271. J Health Psychol. 2018 Jul;23(8):1119-1128 [PMID: 27151069]
  272. Addiction. 2006 Sep;101 Suppl 1:17-22 [PMID: 16930157]
  273. Schizophr Res. 2018 Sep;199:64-74 [PMID: 29606546]
  274. Can J Psychiatry. 2017 Sep;62(9):624-634 [PMID: 28886671]
  275. Schizophr Res. 2003 Apr 1;60(2-3):313-7 [PMID: 12591592]
  276. J Psychiatr Res. 2013 Jul;47(7):858-64 [PMID: 23582710]
  277. Psychopharmacology (Berl). 2015 Dec;232(23):4303-16 [PMID: 26337613]
  278. Nicotine Tob Res. 2016 May;18(5):1157-62 [PMID: 26712843]
  279. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jul 3;52:79-85 [PMID: 23871750]
  280. World Psychiatry. 2021 Oct;20(3):397-404 [PMID: 34505368]
  281. Addiction. 2017 Mar;112(3):401-412 [PMID: 27628300]
  282. Am J Psychiatry. 2014 Nov 1;171(11):1199-205 [PMID: 24934962]
  283. World Psychiatry. 2019 Oct;18(3):360-361 [PMID: 31496093]
  284. Cancer Epidemiol Biomarkers Prev. 2019 Nov;28(11):1934-1943 [PMID: 31270101]
  285. N Engl J Med. 2016 Jan 28;374(4):363-71 [PMID: 26816013]
  286. BMJ. 2015 Sep 21;351:h4065 [PMID: 26391240]
  287. Am J Psychiatry. 2001 Aug;158(8):1184-90 [PMID: 11481147]
  288. J Am Psychiatr Nurses Assoc. 2009 Feb;15(1):32-40 [PMID: 21665792]
  289. Front Psychiatry. 2022 Jan 27;13:804055 [PMID: 35153877]
  290. Addiction. 2016 Jan;111(1):129-41 [PMID: 26582269]
  291. Am J Public Health. 2014 Aug;104(8):1557-65 [PMID: 23948001]
  292. Schizophr Bull. 2011 Jul;37(4):832-8 [PMID: 20019128]
  293. CNS Drugs. 2001;15(6):469-94 [PMID: 11524025]
  294. Thorax. 2013 Nov;68(11):1037-42 [PMID: 23404838]

MeSH Term

Humans
Psychiatry
Tobacco Use Disorder
Journal Article

Word Cloud

Created with Highcharts 10.0.0populationSpanishSocietyTobaccoUseDisorderTUDhealthproblemfirstorderworldaffectingvulnerablepeoplementaldisorderswhosemorbiditymortalityincreasedresultTOBACCOUSEDISORDERANDDUALDISORDERSJointstatementPsychiatryDualDisorders

Similar Articles

Cited By